Skip to Content
Merck
  • Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole.

Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole.

Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology (2011-03-25)
Rola Hussein, Mustapha El-Halabi, Ola Ghaith, Nawaf Jurdi, Cecilio Azar, Nabil Mansour, Ala I Sharara
ABSTRACT

Drug-induced liver injury (DILI) is a leading cause of acute liver failure and is the most frequent reason for post-marketing drug withdrawal. The spectrum of liver injury is wide, ranging from mild and subclinical injury, noticeable only on routine biochemical testing, to fulminant liver failure and death. Antibiotics, as a group, are a leading cause of DILI. We herein describe 4 patients who developed moderate to severe hepatotoxicity after exposure to a commercially - available combination of two antibiotics - spiramycin and metronidazole - commonly used for the treatment and prevention of periodontal infections. No other aetiology for liver injury could be identified in all cases. Two patients recovered spontaneously, and two had a more severe course, one responding to corticosteroids and mycophenolate mofetil and the other requiring liver transplantation for subacute massive necrosis.

MATERIALS
Product Number
Brand
Product Description

Supelco
Spiramycin from Streptomyces sp., VETRANAL®, analytical standard, mixture of isomers
Sigma-Aldrich
Spiramycin
Spiramycin, European Pharmacopoeia (EP) Reference Standard